Openbookopenbook
Equity
Zhong Yuan Bio-Technology Holdings Limited(ZHYBF)
USD --+0.00%
Reward43Moderate
Risk77High
📊75%Data
Revenue down 24% YoY
ZHYBF
+0.0 · +0.00%
USD · PINK
Zhong Yuan Bio-Technology Holdings Limited | Consumer Defensive
Balanced
Market Cap:35.75M
ℹ️
Reward Rating
43
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
77
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ZHYBF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Zhong Yuan Bio-Technology Holdings Limited?

Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China.

ZHYBF · Verdict

Moderate reward · high risk

ZHYBF has limited near-term tailwinds — valuation and volatility weigh on the model output.

Based on 88% data coverage

ZHYBF · Verdict

What’s working & what to watch

Watchouts 5

  • Valuation0/100

    Weak vs peers

  • Volatility5/100

    Weak vs peers

  • Balance sheet19/100

    Interest covered 4.3×

  • Cash flow44/100

    -33% free-cash-flow margin

  • Growth45/100

    Revenue -0.7% CAGR

Model-based scoring. For information only — not financial advice.

What is Zhong Yuan Bio-Technology Holdings Limited?

Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. The company is listed on the PINK in USA, operating in the Consumer Defensive sector, with a market capitalisation of 35.75M, and a P/E ratio of 101.0x.

Financial Highlights

Investment Breakdown

📈 Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (43)

The scoring profile indicates limited reward potential at this time, with profitability and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorConsumer Defensive
Market Cap35.75M
P/E Ratio101
Dividend YieldN/A
52 Week High2.34
52 Week Low2
Last AnnualMarch
IPO DateN/A
IncorporatedUSA
Shares Outstanding18M
No. of Employees23
IndustryPackaged Foods
ExchangePINK
Beta4.645
CurrencyUSD
Websitewww.zhybiotech.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.